Elicio Therapeutics, Inc. (ELTX)
2.98
-0.06
(-1.97%)
USD |
NASDAQ |
Aug 24, 16:00
2.98
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -864.1% |
| December 31, 2021 | 57.40% |
| September 30, 2021 | -1.08K% |
| June 30, 2021 | -3.16K% |
| March 31, 2021 | -9.89K% |
| Date | Value |
|---|---|
| December 31, 2020 | -6.29K% |
| September 30, 2020 | -2.14K% |
| June 30, 2020 | -2.79K% |
| March 31, 2020 | -1.53K% |
| December 31, 2019 | -2.30K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Precigen, Inc. | 36.51% |
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.37K% |
| Return on Assets | -137.4% |
| Return on Invested Capital | -218.1% |
| Return on Net Operating Assets | -627.9% |